EGFRMutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry-Reference-Cited by-同舟云学术

EGFRMutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry

Published:2010-06 Issue:6 Volume:133 Page:922-934
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Sholl Lynette M.,Xiao Yun,Joshi Victoria,Yeap Beow Y.,Cioffredi Leigh-Anne,Jackman David M.,Lee Charles,Jänne Pasi A.,Lindeman Neal I.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/6/922/5004145/ajcpath133-0922.pdf

Reference41 articles.

1. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

2. Epidermal growth factor receptor mutations in lung cancer

3. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

4. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

5. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

2. Molecular Pathology of Lung Tumors;Molecular Surgical Pathology;2023

3. Specimen Considerations in Molecular Oncology Testing;Clinics in Laboratory Medicine;2022-09

4. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients;Journal of Cancer Research and Clinical Oncology;2021-10-24

5. p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair;Neoplasia;2021-07